GLP R Series

Introducing the GLP R Series - GLP-3 R is a novel multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors, studied for the treatment of obesity and metabolic disorders. It promotes weight loss by enhancing energy expenditure, reducing appetite, and improving insulin sensitivity. Early clinical trials have shown promising results, with significant reductions in mass and improvements in glycemic control, positioning it as a potential breakthrough studied peptide.